Pneumagen Ltd
- Biotech or pharma, therapeutic R&D
Pneumagen is a Phase 2 clinical stage company focusing on the development of Neumifil a broad-spectrum anti-viral, broad-spectrum product for the prevention of viral infection and the virus exacerbation of disease such as COPD & Asthma.